Developing a Privacy Conscience: Avoiding a Cambridge Analytica-Type Crisis (Or at Least Be Prepared for One) - Swoop

Developing a Privacy Conscience: Avoiding a Cambridge Analytica-Type Crisis (Or at Least Be Prepared for One)

The mission of the pharmaceutical industry is straightforward: Educate patients about disease states and the therapies that could effectively treat their conditions, as well as enable them to become active participants in their medical journey. But while the “what” pharmaceutical companies can say and the “how” they must say it is well regulated by the FDA, the privacy challenge comes from the “who” you can educate and how you choose to target them. These very real privacy issues are compounded by an increasingly complex set of federal and state laws, as well as self-regulatory guidelines. Privacy issues are probably unavoidable. But are you prepared? Our CEO Ron Elwell moderated a panel discussion on how you can meet the privacy challenges of today and the future by developing a deeper awareness of your company, your patient and your advertising supply chain.

Director, Group Privacy Policies Counsel


Co-Founder and COO Savvy Cooperative


Partner


Swoop
Swoop
Transforming Omnichannel

Swoop is a market leader in privacy-safe, award-winning omnichannel healthcare marketing solutions. Our platform connects patients, HCPs, and brands at scale across all channels, delivering unmatched engagement and proximity to patients throughout their health journey. By combining AI-driven technology with real-world data (RWD), first- and zero-party data, and engagement data, Swoop empowers pharma marketers to make faster, more precise decisions that improve patient outcomes.